• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类尿苷二磷酸葡萄糖醛酸基转移酶UGT1A10可将霉酚酸葡糖醛酸化。

The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid.

作者信息

Mojarrabi B, Mackenzie P I

机构信息

Department of Clinical Pharmacology, Flinders University of South Australia, Bedford Park.

出版信息

Biochem Biophys Res Commun. 1997 Sep 29;238(3):775-8. doi: 10.1006/bbrc.1997.7388.

DOI:10.1006/bbrc.1997.7388
PMID:9325166
Abstract

The cDNA encoding the UDP glucuronosyltransferase, UGT1A10, has been cloned from human colon. The deduced amino acid sequence of the cDNA is 90% similar in sequence to that of a previously characterized form, UGT1A9 (Hlug P4), and contains a signal peptide and carboxyl-terminal hydrophobic domain characteristic of all UDP glucuronosyltransferases isolated to date. The enzyme synthesized in UGT1A10 cDNA-transfected COS-7 cells has a relative molecular mass of 56 kDa and is very active in the glucuronidation of mycophenolic acid (apparent Km of 34 microM and Vmax of 0.6 nmoles/min/mg protein). Other UGTs (UGT1A1, 1A3, 1A4, 1A6, 1A9, 2B7, 2B10 and 2B11) synthesized in COS cells had relatively little activity towards mycophenolic acid, suggesting that UGT1A10 may have a significant role in the elimination of this antineoplastic and immunosuppressive agent in vivo.

摘要

编码尿苷二磷酸葡萄糖醛酸基转移酶UGT1A10的cDNA已从人结肠中克隆出来。该cDNA推导的氨基酸序列与先前鉴定的UGT1A9(Hlug P4)形式的序列有90%的相似性,并且包含一个信号肽和羧基末端疏水结构域,这是迄今为止分离出的所有尿苷二磷酸葡萄糖醛酸基转移酶的特征。在转染了UGT1A10 cDNA的COS-7细胞中合成的酶相对分子质量为56 kDa,并且在霉酚酸的葡萄糖醛酸化反应中非常活跃(表观Km为34 microM,Vmax为0.6纳摩尔/分钟/毫克蛋白质)。在COS细胞中合成的其他UGT(UGT1A1、1A3、1A4、1A6、1A9、2B7、2B10和2B11)对霉酚酸的活性相对较低,这表明UGT1A10可能在体内消除这种抗肿瘤和免疫抑制剂中起重要作用。

相似文献

1
The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid.人类尿苷二磷酸葡萄糖醛酸基转移酶UGT1A10可将霉酚酸葡糖醛酸化。
Biochem Biophys Res Commun. 1997 Sep 29;238(3):775-8. doi: 10.1006/bbrc.1997.7388.
2
cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3.
Biochem Biophys Res Commun. 1996 Aug 23;225(3):785-90. doi: 10.1006/bbrc.1996.1251.
3
How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?高度同源的 UDP-葡糖醛酸基转移酶(UGT)1A9 和 UGT1A10 之间的活性差异有多大,是由多少个氨基酸造成的?
Drug Metab Dispos. 2010 Apr;38(4):687-96. doi: 10.1124/dmd.109.031229. Epub 2010 Jan 20.
4
An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity.人和大鼠肝脏微粒体霉酚酸葡萄糖醛酸化的研究:UGT1A酶起主要作用及UGT1A特异性存在种属差异的证据
Drug Metab Dispos. 2005 Oct;33(10):1513-20. doi: 10.1124/dmd.105.004663. Epub 2005 Jul 20.
5
Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.N端结构域组氨酸和脯氨酸残基对人尿苷二磷酸葡萄糖醛酸基转移酶1A1、1A6、1A9、2B7和2B10底物选择性的影响
Drug Metab Dispos. 2009 Sep;37(9):1948-55. doi: 10.1124/dmd.109.028225. Epub 2009 Jun 1.
6
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.参与霉酚酸Ⅱ相代谢的尿苷二磷酸葡萄糖醛酸基转移酶同工型的鉴定。
Drug Metab Dispos. 2005 Jan;33(1):139-46. doi: 10.1124/dmd.104.001651. Epub 2004 Oct 6.
7
cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.人肝脏UDP-葡萄糖醛酸基转移酶2B亚家族两个新成员的cDNA克隆与表达
Biochem Biophys Res Commun. 1993 Jul 15;194(1):496-503. doi: 10.1006/bbrc.1993.1847.
8
Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.鉴定负责保泰松C-葡萄糖醛酸化的人尿苷二磷酸葡萄糖醛酸基转移酶同工型。
Arch Biochem Biophys. 2006 Oct 1;454(1):72-9. doi: 10.1016/j.abb.2006.07.010. Epub 2006 Aug 7.
9
Cloning and characterization of a canine UDP-glucuronosyltransferase.犬尿苷二磷酸葡萄糖醛酸基转移酶的克隆与特性分析
Arch Biochem Biophys. 2001 Jul 15;391(2):218-24. doi: 10.1006/abbi.2001.2383.
10
Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4.
Arch Biochem Biophys. 1997 Aug 15;344(2):357-64. doi: 10.1006/abbi.1997.0214.

引用本文的文献

1
Glucuronidated Flavonoids in Neurological Protection: Structural Analysis and Approaches for Chemical and Biological Synthesis.神经保护中的葡萄糖醛酸化黄酮类化合物:结构分析及化学与生物合成方法
J Agric Food Chem. 2017 Sep 6;65(35):7607-7623. doi: 10.1021/acs.jafc.7b02633. Epub 2017 Aug 21.
2
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.药物遗传学和影响因素对肾移植临床结局的影响。
Expert Opin Drug Metab Toxicol. 2011 Jun;7(6):731-43. doi: 10.1517/17425255.2011.570260. Epub 2011 Mar 25.
3
Effects of Andrographis paniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms.
穿心莲和鸡骨草提取物对人 UGT 同工酶催化 4-甲基伞形酮葡萄糖醛酸苷反应的影响。
Molecules. 2010 May 14;15(5):3578-92. doi: 10.3390/molecules15053578.
4
The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes.人肝脏、肾脏和空肠微粒体对霉酚酸的葡萄糖醛酸化作用。
Br J Clin Pharmacol. 2001 Nov;52(5):605-9. doi: 10.1046/j.0306-5251.2001.01487.x.
5
Glucuronidation in humans. Pharmacogenetic and developmental aspects.人类的葡萄糖醛酸化作用。药物遗传学及发育方面。
Clin Pharmacokinet. 1999 Jun;36(6):439-52. doi: 10.2165/00003088-199936060-00005.
6
Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.霉酚酸酯治疗的移植受者血浆中霉酚酸的葡萄糖苷和羧基连接的葡萄糖醛酸苷缀合物的鉴定。
Br J Pharmacol. 1999 Mar;126(5):1075-82. doi: 10.1038/sj.bjp.0702399.